Citations (186)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Shaoxiong Wang, Shuizi Ding, Hong Luo & Xiangping Chai. (2021) International Normalized Ratio to Albumin Ratio (PTAR): An Objective Risk Stratification Tool in Patients with Sepsis. International Journal of General Medicine 14, pages 1829-1841.
Read now
Read now
Ying C. Ou, Richard A. Preston, Thomas C. Marbury, Zhiyu Tang, William Novotny, Manal Tawashi, Ta-Kai Li & Srikumar Sahasranaman. (2020) A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment. Leukemia & Lymphoma 61:6, pages 1355-1363.
Read now
Read now
Constantin Dreher, Katrine I. Høyer, Mette Marie Fode, Daniel Habermehl, Stephanie E. Combs & Morten Høyer. (2016) Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma. Acta Oncologica 55:7, pages 886-891.
Read now
Read now
André J Scheen. (2014) Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opinion on Drug Metabolism & Toxicology 10:6, pages 839-857.
Read now
Read now
Malte H. Wehmeyer, Sarah Krohm, Friederike Kastein, Ansgar W. Lohse & Stefan Lüth. (2014) Prediction of spontaneous bacterial peritonitis in cirrhotic ascites by a simple scoring system. Scandinavian Journal of Gastroenterology 49:5, pages 595-603.
Read now
Read now
Sven Wallerstedt, Magnus Simrén, Staffan Wahlin, Lars Lööf, Rolf Hultcrantz, Klas Sjöberg, Hanna Sandberg Gertzén, Hanne Prytz, Sven Almer & Anders Odén. (2013) Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis. Scandinavian Journal of Gastroenterology 48:3, pages 358-365.
Read now
Read now
Yi-wen Huang, Sien-Sing Yang & Jia-Horng Kao. (2011) Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepatic Medicine: Evidence and Research 3, pages 1-11.
Read now
Read now
John W. Haukeland, Linn T. Schreiner, Inger Lorgen, Svein-Oskar Frigstad, Christina Bang, Nils Raknerud & Zbigniew Konopski. (2008) ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis. Scandinavian Journal of Gastroenterology 43:10, pages 1241-1248.
Read now
Read now
H. Bell, J. Jahnsen, E. Kittang, N. Raknerud & L. Sandvik. (2004) Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit. Scandinavian Journal of Gastroenterology 39:9, pages 858-863.
Read now
Read now
M. Bergström, C. Söderman & L. S. Eriksson. (1993) A simplified method to determine galactose elimination capacity in patients with liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 53:7, pages 667-670.
Read now
Read now
Articles from other publishers (176)
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, Hajer Ben Khadhra, Philippe Merle, Giuliana Amaddeo, Nathalie Ganne-Carrie, Christine Silvain, Jean-Marie Peron, Philippe Mathurin, Rodolphe Anty, Thomas Uguen, Thomas Decaens, Ghassan Riachi, Mohamed Bouattour, Aurore Baron, Jean-Pierre Bronowicki, Georges-Philippe Pageaux, Olivier Rosmorduc, Gérard Ducournau, Mélina Gilberg, Alexandre Tanang, Julien Dupin, Anika Gilbert-Marceau & Jean-Frédéric Blanc. (2023) Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort. European Journal of Gastroenterology & Hepatology.
Crossref
Crossref
Aparna Pande, Rashmi Ramachandran & Vimi Rewari. 2023. Peri-operative Anesthetic Management in Liver Transplantation. Peri-operative Anesthetic Management in Liver Transplantation
63
74
.
Seung-Hyun Jeong, Ji-Hun Jang & Yong-Bok Lee. (2022) Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling. Pharmaceutics 14:12, pages 2720.
Crossref
Crossref
Seung-Hyun Jeong, Ji-Hun Jang & Yong-Bok Lee. (2022) Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with Cirrhosis. Journal of Pharmaceutical Sciences 111:11, pages 3174-3184.
Crossref
Crossref
Hossein Karballaei-Mirzahosseini, Romina Kaveh-Ahangaran, Bita Shahrami, Mohammad Reza Rouini, Atabak Najafi, Arezoo Ahmadi, Sima Sadrai, Amirmahdi Mojtahedzadeh, Farhad Najmeddin & Mojtaba Mojtahedzadeh. (2022) Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection. DARU Journal of Pharmaceutical Sciences 30:2, pages 311-322.
Crossref
Crossref
Uta Schilling, Chih‐Hsuan Hsin, Stephane Delahaye, Andreas Krause, Hauke Wuelfrath, Atef Halabi & Jasper Dingemanse. (2022)
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the
P2Y12
receptor antagonist selatogrel
. Clinical and Translational Science 15:8, pages 1906-1915.
Crossref
Crossref
Samer Al-Dury, Johan Waern, Jesper Waldenström, Marko Alavanja, Hevar Hamah Saed, Andreas Törnell, Mohammad Arabpour, Hanna Grauers Wiktorin, Sigrun Einarsdottir, Johan Ringlander, Gisela Ringström, Kristoffer Hellstrand, Anna Martner & Martin Lagging. (2022) Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination. JHEP Reports 4:7, pages 100496.
Crossref
Crossref
Xiao-Fu Chen. (2022) Prognostic Role of MELD-Lactate in Cirrhotic Patients’ Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-8.
Crossref
Crossref
Jo-Nan Liao, Ling Kuo, Chih-Min Liu, Shih-Ann Chen & Tze-Fan Chao. (2022) Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases. European Heart Journal Supplements 24:Supplement_A, pages A11-A18.
Crossref
Crossref
Pin-Shuo Su, Sih-Hsien Wu, Chi-Jen Chu, Chien-Wei Su, Chung-Chi Lin, Shou-Dong Lee, Yuan-Jen Wang, Fa-Yauh Lee, Yi-Hsiang Huang & Ming-Chih Hou. (2021) Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis. Journal of the Chinese Medical Association 85:2, pages 152-159.
Crossref
Crossref
Osman Öcal, Bora Peynircioglu, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Christoph J. Zech, Christian Sengel, Irene Bargellini, Roberto Iezzi, Alberto Benito, Kerstin Schütte, Antonio Gasbarrini, Ricarda Seidensticker, Moritz Wildgruber, Maciej Pech, Peter Malfertheiner, Jens Ricke & Max Seidensticker. (2021) Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. European Radiology 32:2, pages 1320-1329.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
1
108
.
Mostafa M. Elkholy & Ragaey A. Eid. (2021) Quantitative motor unit potential analysis and nerve conduction studies for detection of subclinical peripheral nerve dysfunction in patients with compensated liver cirrhosis. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57:1.
Crossref
Crossref
Giuseppe Ancona, Laura Alagna, Andrea Lombardi, Emanuele Palomba, Valeria Castelli, Giulia Renisi, Daniele Dondossola, Massimo Iavarone, Antonio Muscatello, Andrea Gori & Alessandra Bandera. (2021) The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections. Infection and Immunity 89:11.
Crossref
Crossref
Natalie LY Ngu, Patricia Anderson, Jo Hunter, Anita Figredo, Timothy Papaluca, Stephen Pianko, Anouk Dev, Sally Bell & Suong Le. (2021)
Short‐term intraperitoneal catheters: An ambulatory care intervention for refractory ascites secondary to cirrhosis during
COVID
‐19
. JGH Open 5:10, pages 1154-1159.
Crossref
Crossref
Arun Singh Tejavath, Amit Mathur, Deepak Nathiya, Pratima Singh, Preeti Raj, Supriya Suman, Payal Ramakant Mundada, Sheikh Atif, Ramesh Roop Rai & Balvir Singh Tomar. (2021) Impact of Branched Chain Amino Acid on Muscle Mass, Muscle Strength, Physical Performance, Combined Survival, and Maintenance of Liver Function Changes in Laboratory and Prognostic Markers on Sarcopenic Patients With Liver Cirrhosis (BCAAS Study): A Randomized Clinical Trial. Frontiers in Nutrition 8.
Crossref
Crossref
Takumi Umemura, Kazuki Nishikawa, Yoshikazu Mutoh, Hajime Sasano, Koji Kozaki, Tetsuya Yamada & Toshihiko Ichihara. (2021) Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child–Pugh class C. Journal of Antimicrobial Chemotherapy 76:7, pages 1947-1948.
Crossref
Crossref
Tudor Mocan, Dong Wook Kang, Billy J. Molloy, Hyeonho Jeon, Zeno A. Spârchez, Diren Beyoğlu & Jeffrey R. Idle. (2021) Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis. Scientific Reports 11:1.
Crossref
Crossref
Xiao-Fu Chen, Yuan Zhao, Wei-Zhen Chen, Xin-Tian Shao & Zhi-Ming Huang. (2021) Lactate and Bilirubin Index: A New Indicator to Predict Critically Ill Cirrhotic Patients’ Prognosis. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-7.
Crossref
Crossref
Sravanthi Cheeti, Yuzhong Deng, Ilsung Chang, Isabela Georgescu, Ian Templeton, Nicholas Choong, Kit Wun Kathy Cheung, Sandhya Girish & Luna Musib. (2020) Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics. Clinical Pharmacology in Drug Development 10:2, pages 144-152.
Crossref
Crossref
Rawan Alraish, Sebastian G. Wicha, Otto R. Frey, Anka C. Roehr, Johann Pratschke, Martin Stockmann, Tilo Wuensch & Magnus Kaffarnik. (2020) Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx). Annals of Intensive Care 10:1.
Crossref
Crossref
A. L. Vertkin, Yu. V. Sedyakina, E. G. Silina, M. M. Shamuilova & E. I. Vovk. (2020) Jaundice syndrome in patient with alcoholic liver disease in therapeutic practice. Medical alphabet:17, pages 5-10.
Crossref
Crossref
Tea L Laursen, Thomas D Sandahl, Konstantin Kazankov, Jacob George & Henning Grønbæk. (2020) Liver-related effects of chronic hepatitis C antiviral treatment. World Journal of Gastroenterology 26:22, pages 2931-2947.
Crossref
Crossref
Anuj Bohra, Thomas Worland, Samuel Hui, Ryma Terbah, Ann Farrell & Marcus Robertson. (2020) Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World Journal of Gastroenterology 26:18, pages 2221-2231.
Crossref
Crossref
Masatsugu Ishii, Osamu Itano, Masahiro Shinoda, Minoru Kitago, Yuta Abe, Taizo Hibi, Hiroshi Yagi, Ayano Takeuchi, Hanako Tsujikawa, Tokiya Abe & Yuko Kitagawa. (2020) Pre-hepatectomy type IV collagen 7S predicts post-hepatectomy liver failure and recovery. World Journal of Gastroenterology 26:7, pages 725-739.
Crossref
Crossref
Peter Dellatore, Avantika Mishra & Vinod Rustgi. 2020. Liver Failure. Liver Failure
91
107
.
Jamil S. Alsahhar & Saleh Elwir. 2020. The Critically Ill Cirrhotic Patient. The Critically Ill Cirrhotic Patient
1
9
.
Qiu-xia Ren, Xin-gang Li, Jin-song Mu, Jing-feng Bi, Chun-hui Du, Yan-hong Wang, Hong Zhu, Peng Lv & Qing-guo Zhao. (2019) Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis. Journal of Pharmaceutical Sciences 108:12, pages 3923-3931.
Crossref
Crossref
Chai-Zhaou Lee, Steven Shinn-Forng Peng, Chee-Seng Lee, Huey-Ling Chen, Yen-Hsuan Ni, Mei-Hwei Chang & Jia-Feng Wu. (2019) Transient elastography correlated with diffusion-weighted magnetic resonance imaging and cholestatic complications. Journal of the Formosan Medical Association 118:11, pages 1522-1527.
Crossref
Crossref
Andrew Wilcock, Sarah Charlesworth, Wendy Prentice, Paul Selby, Maria McKenna, Sarah Cripps, Aisling Considine, Alison Orr, Mark Wright, Mary Mihalyo & Stephen Oxberry. (2019) Prescribing in Chronic Severe Hepatic Impairment. Journal of Pain and Symptom Management 58:3, pages 515-537.
Crossref
Crossref
Athanasia Papazafiropoulou & Andreas Melidonis. (2019) Antidiabetic agents in patients with hepatic impairment. World Journal of Meta-Analysis 7:8, pages 380-388.
Crossref
Crossref
Feng Gao, Xie-lin Huang, Meng-Xing Cai, Miao-tong Lin, Bin-feng Wang, Wei Wu & Zhi-Ming Huang. (2019) Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acute-on-chronic liver failure: a multicenter study. Aging 11:13, pages 4446-4462.
Crossref
Crossref
Feng Gao, Meng-Xing Cai, Miao-Tong Lin, Wei Xie, Ling-Zhi Zhang, Qian-Zi Ruan & Zhi-Ming Huang. (2019) Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis. European Journal of Gastroenterology & Hepatology 31:7, pages 824-831.
Crossref
Crossref
Jun-Chi Xu, Fei Gao, Yi-An Liu, Xiao-Long Zhang, Hui Chen, Xiao-Yan Zhu, Hua-Feng Song, Feng Qian, Ming Li, Chen Yang, Chuan-Wu Zhu & Ping Xu. (2018) Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8+T cell activation. Clinical and Experimental Medicine 19:1, pages 93-104.
Crossref
Crossref
Tetsuo Takehara, Naoya Sakamoto, Shuhei Nishiguchi, Fusao Ikeda, Tomohide Tatsumi, Yoshiyuki Ueno, Hiroshi Yatsuhashi, Yasuhiro Takikawa, Tatsuo Kanda, Minoru Sakamoto, Akihiro Tamori, Eiji Mita, Kazuaki Chayama, Gulan Zhang, Shampa De-Oertel, Hadas Dvory-Sobol, Takuma Matsuda, Luisa M. Stamm, Diana M. Brainard, Yasuhito Tanaka & Masayuki Kurosaki. (2018) Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial. Journal of Gastroenterology 54:1, pages 87-95.
Crossref
Crossref
Aparna Goel, Osama Siddique & Aijaz Ahmed. 2019. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Psychosocial Care of End-Stage Organ Disease and Transplant Patients
139
146
.
T. Wang, M. Yan, D. Tang, L. Xue, T. Zhang, Y. Dong, L. Zhu, X. Wang & Y. Dong. (2018) A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis. Journal of Clinical Pharmacy and Therapeutics 43:6, pages 849-854.
Crossref
Crossref
Yao Yu & Mary Feng. (2018) Radiotherapy for Hepatocellular Carcinoma. Seminars in Radiation Oncology 28:4, pages 277-287.
Crossref
Crossref
Deniz Kuscuoglu, Sabina Janciauskiene, Karim Hamesch, Johannes Haybaeck, Christian Trautwein & Pavel Strnad. (2018) Liver – master and servant of serum proteome. Journal of Hepatology 69:2, pages 512-524.
Crossref
Crossref
John Marcinak, Majid Vakilynejad, Akifumi Kogame & Yoshihiko Tagawa. (2018) Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment. Drugs in R&D 18:2, pages 109-118.
Crossref
Crossref
Celina Ang, Sonia Reichert & Randall F. Holcombe. 2018. The American Cancer Society's Oncology in Practice. The American Cancer Society's Oncology in Practice
100
116
.
Segundo Moran, Aline Mina, Ximena Duque, Nayeli Ortiz-Olvera, Gustavo Rodriguez-Leal, Jose Alfredo Sierra-Ramírez, Roberto Medina-Santillán, Robertino M Mera & Misael Uribe. (2017)
The utility of the
13
C-methacetin breath test in predicting the long-term survival of patients with decompensated cirrhosis
. Journal of Breath Research 11:3, pages 036011.
Crossref
Crossref
Tsutomu Tamai, Akihiko Oshige, Kazuaki Tabu, Eriko Tabu, Syo Ijyuin, Haruka Sakae, Hiroka Onishi, Kaori Muromachi, Akiko Saisyoji, Kohei Oda, Kotaro Kumagai, Seiichi Mawatari, Akihiro Moriuchi, Kazuhiro Sakurai, Tsuyoshi Hori & Akio Ido. (2017) Utility of percutaneous radiofrequency ablation alone or combined with transarterial chemoembolization for early hepatocellular carcinoma. Oncology Letters 14:3, pages 3199-3206.
Crossref
Crossref
Hiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, Azusa Sakamoto, Akihiro Nasu, Hideyuki Komekado, Takashi Nishimura, Ryuichi Kita, Toru Kimura, Hiroko Iijima, Shuhei Nishiguchi & Yukio Osaki. (2017) Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy. Oncology Letters 14:2, pages 1637-1647.
Crossref
Crossref
Tomohiro Takamura, Utaroh Motosugi, Shintaro Ichikawa, Katsuhiro Sano, Hiroyuki Morisaka, Tomoaki Ichikawa, Nobuyuki Enomoto & Hiroshi Onishi. (2016) Usefulness of MR elastography for detecting clinical progression of cirrhosis from child-pugh class A to B in patients with type C viral hepatitis. Journal of Magnetic Resonance Imaging 44:3, pages 715-722.
Crossref
Crossref
Christin Edmark, Mark J. W. McPhail, Max Bell, Tony Whitehouse, Julia Wendon & Kenneth B. Christopher. (2016) LiFe: a liver injury score to predict outcome in critically ill patients. Intensive Care Medicine 42:3, pages 361-369.
Crossref
Crossref
Shigeru Matsushima, Yozo Sato, Hidekazu Yamaura, Mina Kato, Yui Onoda, Shinichi Murata, Yasuhiro Shimizu, Yasutomi Kinosada, Hideyuki Nishiofuku & Yoshitaka Inaba. (2016) Preoperative Evaluation of Posthepatectomy Liver Failure Using MRI-Based Liver Function Indices in Child-Pugh Class A Patient. Open Journal of Radiology 06:02, pages 147-156.
Crossref
Crossref
Clemens Agné & Tim Lankisch. 2016. Praxis der Hepatologie. Praxis der Hepatologie
259
266
.
Clemens Agné & Tim Lankisch. 2016. Praxis der Hepatologie. Praxis der Hepatologie
259
266
.
Steven Shinn-Forng Peng, Yung-Ming Jeng, Wen-Ming Hsu, Justin Cheng-Ta Yang & Ming-Chih Ho. (2015) Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. European Radiology 25:10, pages 2992-3002.
Crossref
Crossref
YAOQING LI, ZHONGTANG LU, ZHEYONG LIANG, DONG JI, PENGFEI ZHANG, QINGGUANG LIU, XIN ZHENG & YINGMIN YAO. (2015) Metastasis-associated in colon cancer-1 is associated with poor prognosis in hepatocellular carcinoma, partly by promoting proliferation through enhanced glucose metabolism. Molecular Medicine Reports 12:1, pages 426-434.
Crossref
Crossref
S. Jayakumar, A. Odulaja, S. Patel, M. Davenport & N. Ade-Ajayi. (2015) Surviving Sengstaken. Journal of Pediatric Surgery 50:7, pages 1142-1146.
Crossref
Crossref
Lissi Hansen, Michael C. Leo, Michael F. Chang, Atif Zaman, Willscott Naugler & Jonathan Schwartz. (2015) Symptom Distress in Patients With End-Stage Liver Disease Toward the End of Life. Gastroenterology Nursing 38:3, pages 201-210.
Crossref
Crossref
Longci Sun, Hong Zhou, Lei Gu, Chunhui Jiang, Ye Liu & Qing Xu. (2015) Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension. International Journal of Surgery 16, pages 31-35.
Crossref
Crossref
Xiao-Pei LiYing LiuChun-Qing Zhang. (2015)
Correlation Between
NAT2
Gene Polymorphism and Cirrhotic Portal Hypertension in the Chinese Population
. Genetic Testing and Molecular Biomarkers 19:3, pages 138-143.
Crossref
Crossref
Clemens Agne & Tim Lankisch. 2015. SpringerReference Innere Medizin. SpringerReference Innere Medizin
1
9
.
Zhi Zhu, Xuren Sun, Jinou Wang, Zhe Sun, Zhenning Wang, Xinyu Zheng & Huimian Xu. (2014) Histopathology-based prognostic score is independent prognostic factor of gastric carcinoma. BMC Cancer 14:1.
Crossref
Crossref
Shigeru Matsushima, Yozo Sato, Hidekazu Yamaura, Mina Kato, Yasutomi Kinosada, Seiichi Era, Kazuya Takahashi & Yoshitaka Inaba. (2014) Visualization of liver uptake function using the uptake contrast-enhanced ratio in hepatobiliary phase imaging. Magnetic Resonance Imaging 32:6, pages 654-659.
Crossref
Crossref
Naglaa A. El-Gendy, Naglaa A. Tawfeek, Rayyh A. Saleh, Enas E. Radwan, Eman E. Ahmad & Rehab A. Mohammed. (2014) Diagnosis of spontaneous bacterial peritonitis. The Egyptian Journal of Internal Medicine 26:2, pages 53-59.
Crossref
Crossref
Jan Rustemeyer, Alex Melenberg, Klaus Junker & Aynur Sari-Rieger. (2014) Osteonecrosis of the maxilla related to long-standing methamphetamine abuse: a possible new aspect in the etiology of osteonecrosis of the jaw. Oral and Maxillofacial Surgery 18:2, pages 237-241.
Crossref
Crossref
Ping Xu, Yong-Jing Chen, Hui Chen, Xiao-Yan Zhu, Hua-Feng Song, Li-Juan Cao & Xue-Feng Wang. (2014)
The Expression of Programmed Death-1 in Circulating CD4
+
and CD8
+
T Cells during Hepatitis B Virus Infection Progression and Its Correlation with Clinical Baseline Characteristics
. Gut and Liver 8:2, pages 186-195.
Crossref
Crossref
Fiona V. Büdingen, Daniel Gonzalez, Amelia N. Tucker & Hartmut Derendorf. (2014) Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments. Therapeutic Advances in Infectious Disease 2:1, pages 17-42.
Crossref
Crossref
Iliass Charif, Kaoutar Saada, Ihssane Mellouki, Mounia El Yousfi, Dafrallah Benajah, Mohamed El Abkari, Adil Ibrahimi & Nourdin Aqodad. (2014) Predictors of Intra-Hospital Mortality in Patients with Cirrhosis. Open Journal of Gastroenterology 04:03, pages 141-148.
Crossref
Crossref
Masayoshi Yada. (2014) Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma. World Journal of Gastroenterology 20:35, pages 12581.
Crossref
Crossref
Sangheun LeeSoo Jung ParkJae Hee Cheon, Tae Il KimWon Ho KimDae Ryong KangSung Pil Hong. (2014) Child-Pugh Score Is an Independent Risk Factor for Immediate Bleeding after Colonoscopic Polypectomy in Liver Cirrhosis. Yonsei Medical Journal 55:5, pages 1281.
Crossref
Crossref
Dagmar Kubitza, Angelika Roth, Michael Becka, Abir Alatrach, Atef Halabi, Holger Hinrichsen & Wolfgang Mueck. (2013) Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. British Journal of Clinical Pharmacology 76:1, pages 89-98.
Crossref
Crossref
Mehmet Inci, Murat Mehmet Rifaioglu, Melek Inci, Murat Celik, Mehmet Demir, Turker Ulutas, Mursel Davarci, Vicdan Koksaldi Motor, Ramazan Davran & Cumali Gokce. (2013) The Investigation of Total PSA, Free PSA, and Free/Total PSA Ratio in Patients With Liver Cirrhosis Patients According to Child-Pugh Score. Urology 81:3, pages 617-622.
Crossref
Crossref
Thomas Carroll, Ronald M. Epstein & Robert Gramling. 2013. Evidence-Based Practice in Palliative Medicine. Evidence-Based Practice in Palliative Medicine
241
243
.
James W. Little, Donald A. Falace, Craig S. Miller & Nelson L. Rhodus. 2013. Little and Falace's Dental Management of the Medically Compromised Patient. Little and Falace's Dental Management of the Medically Compromised Patient
144
168
.
Axel Steinstraesser, Roland Wesch & Annke Frick. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1139
1210
.
W. Chen, G. Tomlinson, M. Krahn & J. Heathcote. (2012) Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma. Journal of Viral Hepatitis 19:8, pages 574-580.
Crossref
Crossref
S. Mahadeva & K.‐L. Goh. (2012) Letter: enteral nutrition in advanced cirrhosis – a case of missing the boat?. Alimentary Pharmacology & Therapeutics 36:2, pages 205-206.
Crossref
Crossref
Abhideep Chaudhary, Sachin Daga, Neerav Goyal, Vasudevan Karisangal Ramaswamy, Shaleen Agarwal, Shishir Pareek, Ramdip Ray, Manav Wadhawan & Subash Gupta. (2012) Emergency Liver Transplant in Patient with Child-Pugh Class C Cirrhosis and Strangulated Umbilical Hernia. Experimental and Clinical Transplantation 11:1, pages 66-67.
Crossref
Crossref
Aldo J. Montano–Loza, Judith Meza–Junco, Carla M.M. Prado, Jessica R. Lieffers, Vickie E. Baracos, Vincent G. Bain & Michael B. Sawyer. (2012) Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 10:2, pages 166-173.e1.
Crossref
Crossref
Catherine Petruff Cheney, Eric Mathew Goldberg & Sanjiv Chopra. 2012. Handbook of Liver Disease. Handbook of Liver Disease
136
149
.
Charles Cha. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
58
64.e2
.
Mei-Ling Sharon Tai, Hamizah Razlan, Khean-Lee Goh, Siti Hawa Mohd Taib, Abdul Halim Mohd Huzaini, Sanjay Rampal & Sanjiv Mahadeva. (2011) Short term nasogastric versus oral feeding in hospitalised patients with advanced cirrhosis: A randomised trial. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 6:6, pages e242-e247.
Crossref
Crossref
Kathleen Butler & Renli Teng. (2013) Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Mild Hepatic Impairment. The Journal of Clinical Pharmacology 51:7, pages 978-987.
Crossref
Crossref
Mei-Ling S Tai, Khean-Lee Goh, Siti Hawa Mohd-Taib, Sanjay Rampal & Sanjiv Mahadeva. (2010) Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis. Nutrition Journal 9:1.
Crossref
Crossref
Peter Jepsen, Hendrik Vilstrup, Peter Ott, Susanne Keiding, Per K Andersen & Niels Tygstrup. (2009) The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study. BMC Gastroenterology 9:1.
Crossref
Crossref
Rudolf E. Stauber, Doris Wagner, Vanessa Stadlbauer, Stefan Palma, Gerald Gurakuqi, Daniela Kniepeiss, Florian Iberer, Karl-Heinz Smolle, Josef Haas & Michael Trauner. (2009) Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver International 29:10, pages 1516-1520.
Crossref
Crossref
Tzu-Min Hung, Shin C. Chang, Wei-Hsuan Yu, Yu-Wen Wang, Cheng Huang, Shao-Chun Lu, Po-Huang Lee & Ming-Fu Chang. (2009) A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis. Hepatology 50:4, pages 1184-1193.
Crossref
Crossref
Fabio C. Vicentini, Luiz A.A. Botelho, Marcelo Hisano, Gustavo X. Ebaid, Marcos Lucon, Antonio M. Lucon & Miguel Srougi. (2009) Are Total Prostate-specific Antigen Serum Levels in Cirrhotic Men Different From Those in Normal Men?. Urology 73:5, pages 1032-1035.
Crossref
Crossref
Ming-Wei Lai, Shiu-Feng Huang, Shi-Ming Lin, Tse-Ching Chen, Chun-Yen Lin, Chun-Nan Yeh, Ta-Sen Yeh, Miin-Fu Chen & Chau-Ting Yeh. (2009)
Expression of the
HCRP1
mRNA in HCC as an independent predictor of disease-free survival after surgical resection
. Hepatology Research 39:2, pages 164-176.
Crossref
Crossref
Pierpaolo Di Micco, Rosanna Di Fiore, Alferio Niglio, Sandro Quaranta, Antonella Angiolillo, Giuseppe Cardillo & Giuseppe Castaldo. (2008) Different outcome of six homozygotes for prothrombin A20210A gene variant. Journal of Translational Medicine 6:1.
Crossref
Crossref
Kazuhisa Uchiyama, Kazunari Mori, Katsuyoshi Tabuse, Masaki Ueno, Satoru Ozawa, Takayuki Nakase, Manabu Kawai, Masaji Tani, Hiroshi Tanimura & Hiroki Yamaue. (2008) Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function. Journal of Hepato-Biliary-Pancreatic Surgery 15:6, pages 596-602.
Crossref
Crossref
Hirofumi Kawanaka, Nao Kinjo, Go Anegawa, Daisuke Yoshida, Shinichi Migoh, Kozou Konishi, Masayuki Ohta, Shohei Yamaguchi, Morimasa Tomikawa, Makoto Hashizume & Yoshihiko Maehara. (2008) Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications. Journal of Gastroenterology and Hepatology 23:7pt2, pages e129-e136.
Crossref
Crossref
F WAGNER, C ASSEMI, C LERSCH, R HART & M CLASSEN. (1990) Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice. Clinical and Experimental Immunology 82:2, pages 344-349.
Crossref
Crossref
V.S. Augusto, O. Castro e Silva, M.E.J. Souza & A.K. Sankarankutty. (2008) Evaluation of the Respiratory Muscle Strength of Cirrhotic Patients: Relationship With Child-Turcotte-Pugh Scoring System. Transplantation Proceedings 40:3, pages 774-776.
Crossref
Crossref
Jame J. Zimmerman, Alain Patat, Virginia Parks, Romain Moirand & Kyle Matschke. (2008) Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Severe Hepatic Impairment. The Journal of Clinical Pharmacology 48:3, pages 285-292.
Crossref
Crossref
Tadashi YoshidaAkira HondaHiroshi MiyazakiYasushi Matsuzaki. (2008) Determination of Key Intermediates in Cholesterol and Bile Acid Biosynthesis by Stable Isotope Dilution Mass Spectrometry. Analytical Chemistry Insights 3, pages ACI.S611.
Crossref
Crossref
Suresh Mallikaarjun, Susan E Shoaf, David W Boulton & Steven L Bramer. (2008) Effects of Hepatic or Renal Impairment on the Pharmacokinetics of Aripiprazole. Clinical Pharmacokinetics 47:8, pages 533-542.
Crossref
Crossref
Brian R. Overholser & Kevin M. Sowinski. (2017) Biostatistics Primer: Part I. Nutrition in Clinical Practice 22:6, pages 629-635.
Crossref
Crossref
Sven Wallerstedt, Rolf Olsson, Magnus Simrén, Ulrika Broomé, Staffan Wahlin, Lars Lööf, Rolf Hultcrantz, Klas Sjöberg, Hanna Sandberg Gertzén, Hanne Prytz & Sven Almer. (2007) Abdominal tenderness in ascites patients indicates spontaneous bacterial peritonitis. European Journal of Internal Medicine 18:1, pages 44-47.
Crossref
Crossref
. 2007. Interdisziplinäre Intensivmedizin. Interdisziplinäre Intensivmedizin
607
638
.
R.D. SCHULICK. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
30
36
.
Luigi Addario, Giuseppe Scaglione, Giovanni Tritto, Giovan Giuseppe Di Costanzo, Massimo De Luca, Filippo Lampasi, Alfonso Galeota Lanza, Francesco P. Picciotto, Maria Teresa Tartaglione, Wanda Utech, Michela Macr`, Eduardo Giannelli & Antonio Ascione. (2006) Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study. European Journal of Gastroenterology & Hepatology 18:7, pages 713-720.
Crossref
Crossref
Catherine C. Crone, Geoffrey M. Gabriel & Andrea DiMartini. (2006) An Overview of Psychiatric Issues in Liver Disease for the Consultation–Liaison Psychiatrist. Psychosomatics 47:3, pages 188-205.
Crossref
Crossref
Reza Khosravan, Brian A. Grabowski, Michael D. Mayer, Jing-Tao Wu, Nancy Joseph-Ridge & Laurent Vernillet. (2006) The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase. The Journal of Clinical Pharmacology 46:1, pages 88-102.
Crossref
Crossref
Gennaro D'Amico, Guadalupe Garcia-Tsao & Luigi Pagliaro. (2006) Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. Journal of Hepatology 44:1, pages 217-231.
Crossref
Crossref
Riccardo Superina. 2006. Pediatric Surgery. Pediatric Surgery
1651
1670
.
Annke Frick, Christopher Marshallsay, Axel Steinstraesser & Roland Wesch. 2006. Drug Discovery and Evaluation. Drug Discovery and Evaluation
659
720
.
James J. Zimmerman, Kenneth C. Lasseter, Heng-Keang Lim, Dawn Harper, Stacey C. Dilzer, Vernon Parker & Kyle Matschke. (2005) Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Mild to Moderate Hepatic Impairment. The Journal of Clinical Pharmacology 45:12, pages 1368-1372.
Crossref
Crossref
Katia Mattarozzi, Claudio Campi, Maria Guarino & Andrea Stracciari. (2005) Distinguishing Between Clinical and Minimal Hepatic Encephalopathy on the Basis of Specific Cognitive Impairment. Metabolic Brain Disease 20:3, pages 243-249.
Crossref
Crossref
Naomi S. BostonJudianne C. Slish. (2016) Management of HIV Infection in Persons Co-infected With Hepatitis. Journal of Pharmacy Practice 18:4, pages 295-309.
Crossref
Crossref
D. Arnal, I. Garutti, J. Perez-Peña, L. Olmedilla & I. G. Tzenkov. (2005) Radial to femoral arterial blood pressure differences during liver transplantation. Anaesthesia 60:8, pages 766-771.
Crossref
Crossref
Emma J. Mullin, Matthew S. Metcalfe & Guy J. Maddern. (2005) How much liver resection is too much?. The American Journal of Surgery 190:1, pages 87-97.
Crossref
Crossref
François Durand & Dominique Valla. (2005) Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD. Journal of Hepatology 42:1, pages S100-S107.
Crossref
Crossref
M.A.M. Marchioretto, C. Ecclissato, C.M.F. da Silva, N.M. Cassiano, S.A. Calafatti, S. Mendonça, M.L. Ribeiro, G.C.R. Bernasconi, M.F. Degger, H. Piovesan & J. Pedrazzoli Jr.. (2005) Plasma hydroxy-metronidazole/ metronidazole ratio in hepatitis C virus-induced liver disease. Brazilian Journal of Medical and Biological Research 38:3, pages 437-444.
Crossref
Crossref
D. Festi. (2005) Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: Comparison with Child-Pugh score and serum bile acid levels. World Journal of Gastroenterology 11:1, pages 142.
Crossref
Crossref
Alfred E. Corey, Jeffrey R. Agnew, Eileen C. King, Nikhil J. Parekh, James H. Powell & Gary A. Thompson. (2004) Effect of Mild and Moderate Hepatic Impairment on Azimilide Pharmacokinetics Following Single Dose Oral Administration. Journal of Pharmaceutical Sciences 93:5, pages 1279-1286.
Crossref
Crossref
Philip D Schneider. (2004) Preoperative assessment of liver function. Surgical Clinics of North America 84:2, pages 355-373.
Crossref
Crossref
Constantinos Chatzicostas, Maria Roussomoustakaki, Georgios Notas, Ioannis G Vlachonikolis, Demetrios Samonakis, John Romanos, Emmanouel Vardas & Elias A Kouroumalis. (2003) A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosis. BMC Gastroenterology 3:1.
Crossref
Crossref
G Park. (2003) Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 38:5, pages 1227-1236.
Crossref
Crossref
Ziv J. Haskal, Chet R. Rees, Ernest J. Ring, Richard Saxon & David Sacks. (2003) Reporting Standards for Transjugular Intrahepatic Portosystemic Shunts. Journal of Vascular and Interventional Radiology 14:9, pages S419-S426.
Crossref
Crossref
Rafael Claudino Botero & Michael R Lucey. (2003) Organ allocation: model for end-stage liver disease, Child-Turcotte-Pugh, Mayo risk score, or something else. Clinics in Liver Disease 7:3, pages 715-727.
Crossref
Crossref
P Rocca. (2003) Predictors of psychiatric disorders in liver transplantation candidates: Logistic regression models. Liver Transplantation 9:7, pages 721-726.
Crossref
Crossref
Giulio Marchesini, Giampaolo Bianchi, Manuela Merli, Piero Amodio, Carmine Panella, Carmela Loguercio, Fillipo Rossi Fanelli & Roberto Abbiati. (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:7, pages 1792-1801.
Crossref
Crossref
Lilian R. O. Aprile, Ulysses G. Meneghelli, Ana L. C. Martinelli & Carlos R. Monteiro. (2002) Gastric Motility in Patients With Presinusoidal Portal Hypertension. American Journal of Gastroenterology 97:12, pages 3038-3044.
Crossref
Crossref
D DI Bona, G Montalto, L Clemenza, F Bascone, P Accardo, D Bellavia, A CraxÌ & M Brai. (1998) Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases. Clinical and Experimental Immunology 114:1, pages 102-105.
Crossref
Crossref
Andrea DiMartini, Nancy Day, Tonya Lane, Amy T. Beisler, Mary Amanda Dew & Raymond Anton. (2001) Carbohydrate Deficient Transferrin in Abstaining Patients With End-Stage Liver Disease. Alcoholism: Clinical and Experimental Research 25:12, pages 1729-1733.
Crossref
Crossref
Yasushi Miyazawa, Robert A. Blum, Jerome J. Schentag, Hidetaka Kamimura, Hiroshi Matsushima, Herbert Swarz & Yutaka Ito. (2001) Pharmacokinetics and safety of tamsulosin in subjects with normal and impaired renal or hepatic function. Current Therapeutic Research 62:9, pages 603-621.
Crossref
Crossref
Ihor Bekersky, Dawna Dressler, Ala Alak, Gary W. Boswell & Qais A. Mekki. (2013) Comparative Tacrolimus Pharmacokinetics: Normal versus Mildly Hepatically Impaired Subjects. The Journal of Clinical Pharmacology 41:6, pages 628-635.
Crossref
Crossref
T. Kobayashi, K. Kubota, H. Imamura, K. Hasegawa, Y. Inoue, T. Takayama & M. Makuuchi. (2001)
Hepatic phenylalanine metabolism measured by the [
13
C]phenylalanine breath test
. European Journal of Clinical Investigation 31:4, pages 356-361.
Crossref
Crossref
C. Herold, R. Heinz, M. Radespiel‐Tröger, H. T. Schneider, D. Schuppan & E. G. Hahn. (2008) Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver 21:1, pages 26-30.
Crossref
Crossref
Lindqvist, Westerberg, Bergström, Torsteindottir, Gustafson, Sundin, Lööf & Långström. (2000)
[
11
C]Hyaluronan uptake with positron emission tomography in liver disease
. European Journal of Clinical Investigation 30:7, pages 600-607.
Crossref
Crossref
Dennis M. Grasela, Barbara Christofalo, Georgia D. Kollia, Glenn Duncan, Robert Noveck, James A. ManningJr.Jr. & Frank P. LaCreta. (2012) Safety and Pharmacokinetics of a Single Oral Dose of Gatifloxacin in Patients with Moderate to Severe Hepatic Impairment. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20:6P2.
Crossref
Crossref
Michael Trauner, Peter Fickert & Rudolf Stauber. 2000. Handbook of Alcoholism. Handbook of Alcoholism
183
194
.
Vibeke Hatorp, Kirsten H. Walther, Michael S. Christensen & Gertraud Haug‐Pihale. (2013) Single‐Dose Pharmacokinetics of Repaglinide in Subjects with Chronic Liver Disease. The Journal of Clinical Pharmacology 40:2, pages 142-152.
Crossref
Crossref
E. Lechler & D. Rein. 2000. 29. Hämophilie-Symposion. 29. Hämophilie-Symposion
189
192
.
M. Bernardi, L. Blendis, A. K. Burroughs, G. Laffi, J. Rodes & P. Gentilini. (1999) Hepatorenal syndrome and ascites - questions and answers. Liver International 19:s1, pages 15-74.
Crossref
Crossref
Da Silva, David, Muscará, Sousa, Ferraz, De Nucci, Polimeno & Pedrazzoli. (2001) Plasma hydroxy‐metronidazole/metronidazole ratio can detect early changes in hepatic function in ethanol‐induced liver injury. Alimentary Pharmacology & Therapeutics 13:10, pages 1335-1341.
Crossref
Crossref
Rc Guptan, V Thakur, V Raina & Sk Sarin. (2001) Alpha‐interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. Journal of Gastroenterology and Hepatology 14:9, pages 893-898.
Crossref
Crossref
Tadashi Yoshida, Akira Honda, Yasushi Matsuzaki, Junichi Shoda, Masato Abei, Naomi Tanaka & Toshiaki Osuga. (2002) Plasma levels of mevalonate and 7α‐hydroxy‐4‐cholesten‐3‐one in chronic liver disease. Journal of Gastroenterology and Hepatology 14:2, pages 150-155.
Crossref
Crossref
Ji-Ye Zhu. (1999) Measurement of liver volume and its clinical significance in cirrhotic portal hypertensive patients. World Journal of Gastroenterology 5:6, pages 525.
Crossref
Crossref
FABRIS, JEMMOLO, TOFFOLO, PALEARI, VIAGGI, RIGON, CASAGRANDE, LIRUSSI, STRAZZABOSCO, COBELLI & OKOLICSANYI. (1999) The monoethylglycinexylidide test for grading of liver cirrhosis. Alimentary Pharmacology & Therapeutics 13:1, pages 67-75.
Crossref
Crossref
Arshad K Butt, Anwaar A Khan, Altaf Alam, Waqar H S Shah, Farzana Shafqat & Altaf Baqir Naqvi. (1998) Predicting hospital mortality in cirrhotic patients: comparison of child-pugh and acute physiology, age and chronic health evaluation (APACHE III) scoring systems. American Journal of Gastroenterology 93:12, pages 2469-2475.
Crossref
Crossref
C. M. F. Da SilvaF. L. DavidM. N. MuscaráS. S. SousaJ. G. P. FerrazG. De NucciN. C. Polimeno & J. Pedrazzoli Jr. (2002) Plasma hydroxy metronidazole/metronidazole ratio in anti‐HCV carriers with and without apparent liver disease. British Journal of Clinical Pharmacology 46:2, pages 176-180.
Crossref
Crossref
Karin M. Jorga, Jan Martin Kroodsma, Baerbel Fotteler, Peter Heizmann, Joseph Meyer, Mareike C. Rasch & Jan van Hattum. (1998) Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites*. Clinical Pharmacology & Therapeutics 63:6, pages 646-654.
Crossref
Crossref
Maria R. Marino, Kathleen M. Langenbacher, Ralph H. Raymond, Neville F. Ford & Kenneth C. Lasseter. (2013) Pharmacokinetics and Pharmacodynamics of Irbesartan in Patients with Hepatic Cirrhosis. The Journal of Clinical Pharmacology 38:4, pages 347-356.
Crossref
Crossref
Claudio Ronco & Rinaldo BellomoJohn J. Brady & John A. Kellum. 1998. Critical Care Nephrology. Critical Care Nephrology
941
947
.
H J SchaadB G PettyD M GraselaB ChristofaloR RaymondM Stewart. (1997) Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment. Antimicrobial Agents and Chemotherapy 41:12, pages 2793-2796.
Crossref
Crossref
A.C. Spósito, C.G. Vinagre, F.L Pandullo, S. Mies, S. Raia & J.A.F. Ramires. (1997) Apolipoprotein and lipid abnormalities in chronic liver failure. Brazilian Journal of Medical and Biological Research 30:11, pages 1287-1290.
Crossref
Crossref
Simon D. Taylor‐Robinson, Janet Sargentoni, Jimmy D. Bell, Nadeem Saeed, K. Kumar Changani, Brian R. Davidson, Keith Rolles, Andrew K. Burroughs, Humphrey J. F. Hodgson, Christopher S. Foster & I. Jane Cox. (2008)
In vivo
and
in vitro
hepatic
31
P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver
. Liver 17:4, pages 198-209.
Crossref
Crossref
J Michael Tredger & Roy A Sherwood. (2016) The Liver: New Functional, Prognostic and Diagnostic Tests. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 34:2, pages 121-141.
Crossref
Crossref
Ziv J. Haskal, Chet R. Rees, Ernest J. Ring, Richard Saxon & David Sacks. (1997) Reporting Standards for Transjugular Intrahepatic Portosystemic Shunts. Journal of Vascular and Interventional Radiology 8:2, pages 289-297.
Crossref
Crossref
Samy A. Azer, Geoffrey W. McCaughan & Neill H. Stacey. 1997. Liver and Environmental Xenobiotics. Liver and Environmental Xenobiotics
178
203
.
Piero Amodio, Juan C. Quero, Franco Del Piccolo, Angelo Gatta & Solko W. Schalm. (1996) Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG. Metabolic Brain Disease 11:4, pages 315-327.
Crossref
Crossref
Francesco Salerno, Gianmario Borroni, Pamela Moser, Angelo Sangiovanni, Piero Almasio, Gabriele Budillon, Gaetano Capuano, Maurizio Muraca, Giulio Marchesini, Giulio Marchesini, Mauro Bernardi, Giorgio Marenco, Gianpaolo Molino, Lorenzo Rossaro, Antonio Solinas & Antonio Ascione. (1996) Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. Journal of Hepatology 25:4, pages 474-480.
Crossref
Crossref
Gerry Parker, Roy Bullingham, Barbara Kamm & Michael Hale. (2013) Pharmacokinetics of Oral Mycophenolate Mofetil in Volunteer Subjects with Varying Degrees of Hepatic Oxidative Impairment. The Journal of Clinical Pharmacology 36:4, pages 332-344.
Crossref
Crossref
SAMY A. AZER, SHIRLEY A. COVERDALE, KAREN BYTH, GEOFFREY C. FARRELL & NEILL H. STACEY. (2008) Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. Journal of Gastroenterology and Hepatology 11:3, pages 208-215.
Crossref
Crossref
Eberhard L. Renner. (1995) 2 Liver function tests. Baillière's Clinical Gastroenterology 9:4, pages 661-677.
Crossref
Crossref
MN Muscara, J. PedrazzoliJrJr, EL Miranda, JG Ferraz, E. Hofstatter, G. Leite, AF Magalhaes, S. Leonardi & G. De Nucci. (2012) Plasma hydroxy‐metronidazole/metronidazole ratio in patients with liver disease and in healthy volunteers.. British Journal of Clinical Pharmacology 40:5, pages 477-480.
Crossref
Crossref
Simon D. Taylor-Robinson, E.Louise Thomas, Janet Sargentoni, Claude D. Marcus, Brian R. Davidson & Jimmy D. Bell. (1995) Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1272:2, pages 113-118.
Crossref
Crossref
Marco Zoli, Donatella Magalotti, Bianchi Giampaolo, Ghigi Gino, Cristina Orlandini, Michele Grimaldi, Giulio Marchesini & Emilio Pisi. (1995) Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. Journal of Hepatology 23:2, pages 129-134.
Crossref
Crossref
Howard S. Friedman, Nicholas Cirillo, Frank Schiano, Paul Nathan, Sultan Khan, Hugo Rosero, Mehdi Vaseghi, Terrence Sacchi, Balendu Vasavada & Loring Bjornson. (2006) Vasodilatory State of Decompensated Cirrhosis: Relation to Hepatic Dysfunction, Ascites, and Vasoactive Substances. Alcoholism: Clinical and Experimental Research 19:1, pages 123-129.
Crossref
Crossref
Daniel Urbain, Vinciane Muls, Olivier Thys & Hamphrey R. Ham. (1995) Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. Journal of Hepatology 22:2, pages 179-183.
Crossref
Crossref
Neville F. Ford, Kenneth C. Lasseter, Donald R. Van Harken, Janis L. Hammett, Ralph Raymond & James Manning. (2013) Single‐Dose and Steady‐State Pharmacokinetics of Fosinopril and Fosinoprilat in Patients with Hepatic Impairment. The Journal of Clinical Pharmacology 35:2, pages 145-150.
Crossref
Crossref
B.C. Michel, B.A. Van Hout & G.J. Bonsel. (1994) 3 Assessing the benefits of transplant services. Baillière's Clinical Gastroenterology 8:3, pages 411-423.
Crossref
Crossref
Giampaolo Bianchi, Giulio Marchesini, Marco Zoli, Elisabetta Bugianesi, Andrea Fabbri & Emilio Pisi. (1994) Prognostic significance of diabetes in patients with cirrhosis. Hepatology 20:1, pages 119-125.
Crossref
Crossref
TAKASHI SUGIMURA, YUJI TSUJI, MAKI SAKAMOTO, KAZUHIRO KOTOH, TAKAYOSHI FUKUTOMI, HIRONORI SAKAI, SHIGERU SAKAMOTO, KOUHEI AKAZAWA, YOSHIAKI NOSE & HAJIME NAWATA. (2008) Long‐term prognosis and prognostic factors of liver cirrhosis in the 1980s. Journal of Gastroenterology and Hepatology 9:2, pages 154-161.
Crossref
Crossref
G. P. BIANCHI, G. MARCHESINI, R. BOLZANI, A. FABBRI, E. SARTI & E. PISI. (2008) Model‐derived assessment of urea appearance in response to alanine infusion: A quantitative measure of liver function in cirrhosis. Journal of Gastroenterology and Hepatology 8:6, pages 550-556.
Crossref
Crossref
Marco Zoli, Tiziana Iervese, Carlo Merkel, Giampaolo Bianchi, Donatella Magalotti, Giulio Marchesini, Angelo Gatta & Emilio Pisi. (1993) Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. Journal of Hepatology 17:1, pages 56-61.
Crossref
Crossref
Fabio Farinati, Lucia Dalri'Lorenzo Rossaro, Mario Plebani, Lucia Nemetz, Patrizia Boccagni, Nicolo Bassi & Remo Naccarato. (1993) Serum and salivary caffeine clearance in cirrhosis. Any role in selection for surgery and timing for transplantation?. Journal of Hepatology 18:1, pages 135-136.
Crossref
Crossref
Leo Strunin. (1992) Preoperative assessment of hepatic function. Baillière's Clinical Anaesthesiology 6:4, pages 781-793.
Crossref
Crossref
Frederick W. Lewis & William G. RectorJr.Jr.. (1992) Caffeine clearance in cirrhosis. Journal of Hepatology 14:2-3, pages 157-162.
Crossref
Crossref
M. Adler, N. Bourgeois, J. van de Stadt & M. Gelin. (1992) A Pugh score of 8 adequately selects patients with parenchymal cirrhosis for liver transplantation. Transplant International 5, pages S175-S178.
Crossref
Crossref
P. Amodio, S. Bellon, C. Merkel, M. Bolognesi & A. Gatta. (1992) Are prealbumin plasma levels linked to amino acid supply from peripheral tissues in liver cirrhosis?. Amino Acids 3:3, pages 223-228.
Crossref
Crossref
M. Adler, N. Bourgeois, J. van de Stadt & M. Gelin. 1992. Transplant International Official Journal of the European Society for Organ Transplantation. Transplant International Official Journal of the European Society for Organ Transplantation
175
178
.
Michael Oellerich, Martin Burdelski, Hans-Ulrich Lautz, Lutz Binder & Rudolf Pichlmayr. (1991) Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 14:6, pages 1029-1034.
Crossref
Crossref
Carlo Merkel, Angelo Gatta, Marco Zoli, Massimo Bolognesi, Paolo Angeli, Tiziana Iervese, Giulio Marchesini & Arturo Ruol. (1991) Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Digestive Diseases and Sciences 36:9, pages 1197-1203.
Crossref
Crossref
Jürg Reichen, Thomas Widmer & Jacques Cotting. (1991) Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: A comparison with the mayo model. Hepatology 14:3, pages 504-510.
Crossref
Crossref
Richard Sallie, J. Michael Tredger & Roger Williams. (2006) Drugs and the liver part 1: Testing liver function. Biopharmaceutics & Drug Disposition 12:4, pages 251-259.
Crossref
Crossref
Gianpaolo Molino. (1991) The functioning liver mass. La Ricerca in Clinica e in Laboratorio 21:1, pages 9-40.
Crossref
Crossref
NIELS TYGSTRUP. (2008) Assessment of liver function: Principles and practice. Journal of Gastroenterology and Hepatology 5:4, pages 468-482.
Crossref
Crossref
JÜRg Reichen. (1990) Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 11:6, pages 1066-1078.
Crossref
Crossref